Raymond Novak
- Molecular Biology top 5%
- Pharmacology top 0.1%
- Oncology top 5%
- Biochemistry top 1%
- Cancer Research top 5%
- Co-authors
- Kimberley J. WoodcroftSang Kyum KimEvan D. KharaschRichard C. ZangarSang G. KimSang Geon KimMikehl S. HafnerAlice Hudder
- Topics
- Pharmacogenetics and Drug Metabolism (45 papers)Drug Transport and Resistance Mechanisms (19 papers)Glutathione Transferases and Polymorphisms (16 papers)
- Partner nations
- United StatesSouth KoreaHungary
In The Last Decade
Raymond Novak
138 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 129
- Molecular Biology 1.5k
- Pharmacology 1.2k
- Oncology 734
- Biochemistry 461
- Cancer Research 436
Countries citing papers authored by Raymond Novak
This map shows the geographic impact of Raymond Novak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Novak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Novak more than expected).
Fields of papers citing papers by Raymond Novak
This network shows the impact of papers produced by Raymond Novak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Novak. The network helps show where Raymond Novak may publish in the future.
Co-authorship network of co-authors of Raymond Novak
This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Novak. A scholar is included among the top collaborators of Raymond Novak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Novak. Raymond Novak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 157 | |
| 3 | 20 | |
| 4 | 47 | |
| 5 | 51 | |
| 6 | 48 | |
| 7 | 24 | |
| 8 | 38 | |
| 9 | 29 | |
| 10 | 123 | |
| 11 | 33 | |
| 12 | 7 | |
| 13 | 18 | |
| 14 | 30 | |
| 15 | 58 | |
| 16 | 4 | |
| 17 | 10 | |
| 18 | 6 | |
| 19 | 82 | |
| 20 | 4 |
About Raymond Novak
Raymond Novak is a scholar working on Pharmacology, Biophysics and Biochemistry, having authored 140 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (19 papers) and Glutathione Transferases and Polymorphisms (16 papers). The work is most often cited by research in Pharmacology (1.2k citations), Biochemistry (461 citations) and Cancer Research (436 citations). Raymond Novak has collaborated with scholars based in United States, South Korea and Hungary. Frequent co-authors include Kimberley J. Woodcroft, Sang Kyum Kim, Evan D. Kharasch, Richard C. Zangar, Sang G. Kim, Sang Geon Kim, Mikehl S. Hafner, Alice Hudder, B. Matkovics and Mohamed A. Abdelmegeed. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.